Current Neuro-Oncology

Volume 25 Number 4
28 February 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 4, 28 February


Joerger M, Hundsberger T, Haefliger S, von Moos R, Hottinger AF, Kaindl T, Engelhardt M, Marszewska M, Lane H, Roth P, Stathis A.
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
Invest New Drugs. 2023 Feb 16
. doi: 10.1007/s10637-023-01336-9. PMID: 36792805. Interventional study. ˍ

Tuna G, Bekar NED, İşlekel S, İşlekel GH.
Urinary 8-hydroxy-2'-deoxyguanosine levels are elevated in patients with IDH1-wildtype glioblastoma and are associated with tumor recurrence in gliomas.
DNA Repair (Amst). 2023 Feb 16;124:103463
. doi: 10.1016/j.dnarep.2023.103463. PMID: 36841018. Laboratory investigation˰ ˍ


Agar MR, Nowak AK, Hovey EJ, Barnes EH, Simes J, Vardy JL, Wheeler HR, Kong BY, Leonard R, Hall M, Tim E, Spyridopoulos D, Sim HW, Lwin Z, Dowling A, Harrup R, Jennens R, Kichenadasse G, Dunlop T, Gzell C, Koh ES.
Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.
BMJ Support Palliat Care. 2023 Feb 17:spcare-2022-004119
. doi: 10.1136/spcare-2022-004119. PMID: 36807048. Interventional study˰ ˍ

Goldsmith HS.
Introduction of chemotherapy by omentum for a glioblastoma WHO-IV.
Surg Neurol Int. 2023 Feb 17;14:59. doi: 10.25259/SNI_1080_2022. PMID: 36895220. Editorial. ˍ

Yang C, Li ZQ, Wang J.
Association between systemic immune-inflammation index (SII) and survival outcome in patients with primary glioblastoma.
Medicine (Baltimore). 2023 Feb 17;102(7):e33050
. doi: 10.1097/MD.0000000000033050. PMID: 36800573. Observational study. ˍ

Shen F, Li J, Liu F, Sun N, Qiu X, Ding W, Sun X.
The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis.
Front Oncol. 2023 Feb 17;13:1095362. doi: 10.3389/fonc.2023.1095362. PMID: 36874124. Observational study. ˍ


Waqar M, Roncaroli F, Djoukhadar I, Akkari L, O'Leary C, Hewitt L, Forte G, Jackson R, Hessen E, Withington L, Beasley W, Richardson J, Golby C, Whitehurst P, Colaco R, Bailey M, Karabatsou K, D'Urso PI, McBain C, Coope DJ, Borst GR.
Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG) - A phase I trial.
Clin Transl Radiat Oncol. 2023 Jan 18;39:100585
. doi: 10.1016/j.ctro.2023.100585. PMID: 36845633. Interventional study protocol. ˍ


Dunkel IJ, Doz F, Foreman NK, Hargrave D, Lassaletta A, André N, Hansford JR, Hassall T, Eyrich M, Gururangan S, Bartels U, Gajjar A, Howell L, Warad D, Pacius M, Tam R, Wang Y, Zhu L, Cohen K.
Nivolumab With or Without Ipilimumab in Pediatric Patients With High-Grade CNS Malignancies: Safety, Efficacy, Biomarker, and Pharmacokinetics: CheckMate 908.
Neuro Oncol. 2023 Feb 20:noad031
. doi: 10.1093/neuonc/noad031. PMID: 36808285. Interventional study. ˍ

Glavatskyi OY, Griazov AB, Chuvashova OY, Kruchok IV, Griazov AA, Khmelnytskyi HV, Shuba IM, Stuley VA, Zemskova OV.
Radiosurgical treatment of recurrent glioblastoma and prognostic factors affecting treatment outcomes.
Exp Oncol. 2023 Feb 20, 2022;44(4):307-313
. doi: 10.32471/exp-oncology.2312-8852.vol-44-no-4.18920. PMID: 36811543. Observational study. ˍ

Rykkje AM, Larsen VA, Skjøth-Rasmussen J, Nielsen MB, Carlsen JF, Hansen AE.
Timing of Early Postoperative MRI following Primary Glioblastoma Surgery-A Retrospective Study of Contrast Enhancements in 311 Patients.
Diagnostics (Basel). 2023 Feb 20;13(4):795
. doi: 10.3390/diagnostics13040795. PMID: 36832282. Observational study. ˍ

Bigagli E, Agostiniani S, Pugi A, Rombi B, Tornaboni EE, Censullo ML, Gori CG, Pavone R, Sardi I.
Unforeseen cytomegalovirus retinopathy following high dose thiotepa and proton irradiation in a pediatric patient with high-risk medulloblastoma: A case report.
Front Pediatr. 2023 Feb 21;11:1145941. doi: 10.3389/fped.2023.1145941. PMID: 36896395. Case report. ˍ

Ibn Essayed W, Jarvis CA, Bernstock JD, Slingerland A, Albanese J, Friedman GK, Arnaout O, Baird L.
Positioning Transclival Tumor-Treating Fields for the Treatment of Diffuse Intrinsic Pontine Gliomas.
Life (Basel). 2023 Feb 21;13(3):601. doi: 10.3390/life13030601. PMID: 36983757. Observational study. ˍ


Liu Y, Li L, Hu H, Yang J, Zhang X, Chen L, Chen F, Hao S, Li W, Huang G.
Association between preoperative hematocrit and postoperative 30-day mortality in adult patients with tumor craniotomy.
Front Neurol. 2023 Feb 21;14:1059401. doi: 10.3389/fneur.2023.1059401. PMID: 36895901. Observational study. ˍ

Veronese S, Bertocchi E, Lissoni B, Rudà R, Silvani A, Simonetti G, Pisanello A, Ieraci S, Salmaggi A, Merli R, Verza M, De Panfilis L, Solari A, Pace A.
Patient and carer involvement in the formulation of research questions: findings from the Italian guideline on palliative care in adults with glioma.
Neurol Sci. 2023 Feb 21
. doi: 10.1007/s10072-023-06687-y. PMID: 36809422. Interviews˰ ˍ

Xiao D, Yan C, Li D, Xi T, Liu X, Zhu D, Huang G, Xu J, He Z, Wu A, Ma C, Long J, Shu K, Ji H, Wang N, Chen G, Yang J, Ma H, Li Z, Sun X, Qu Y, Liu Z, Jiang X, Tian C, Ni S, Zhan R, Chen L, Ge M, Wang M, Jiang X, Guo G, Han Z, Zhang C, Zhang T, Dou C, Chu L, Wang P, Shao J, Wu X, Yu J, Wang Y, Wu N, Zhang R, Zhang M, Hong Y, Gao J, Li Y, Pan Y, Zhao B, Ji N, Shan G, Patel CB, Jia W, Zhang L.
National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020.
Lancet Reg Health West Pac. 2023 Feb 21;34:100715. doi: 10.1016/j.lanwpc.2023.100715. PMID: 37283963. Observational study. ˍ

Elia A, Bertuccio A, Vitali M, Barbanera A, Pallud J.
Is surgical resection predict overall survival in frail patients with glioblastoma, IDH-wildtype?
Neurochirurgie. 2023 Feb 22;69(2):101417
. doi: 10.1016/j.neuchi.2023.101417. PMID: 36827763. Observational study˰ ˍ

Ladenhauf VK, Galijasevic M, Kerschbaumer J, Freyschlag CF, Nowosielski M, Birkl-Toeglhofer AM, Haybaeck J, Gizewski ER, Mangesius S, Grams AE.
Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma.
Cancers (Basel). 2023 Feb 22;15(5):1384. doi: 10.3390/cancers15051384. PMID: 36900177. Observational study. ˍ

Smolenschi C, Rassy E, Pallud J, Dezamis E, Copaciu R, Parker F, Garcia G, Lezghed N, Colomba E, Khettab M, Ammari S, Fekhi M, Martanovschi L, Benadhou L, Knafo S, Guyon D, Cheaib B, Dhermain F, Dumont SN.
Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
J Neurol. 2023 Feb 22
. doi: 10.1007/s00415-023-11600-w. PMID: 36813928. Observational study˰ ˍ

Zhang C, Zhong X, Yi L, Zhao Z, Zhang Y, Tan G, Zhang Y, Zhang Y, Xu Y, Wu N.
Exploring the Associations between Alzheimer's Disease and GBM Mediated by Microglia Based on Network Analysis.
J Prev Alzheimers Dis. 2023 Feb 22;10(2):267-275. doi: 10.14283/jpad.2023.23. PMID: 36946454. Laboratory investigation˰ ˍ

Ambulkar R, Parab SY, Vignesh B, Nagargoje V, Janu A, Parikh P, Moiyadi A.
A prospective study to evaluate the use of surveillance venous ultrasonography to detect incidence of deep venous thrombosis following neurosurgical excision of brain tumors.
J Neurosci Rural Pract. 2023 Feb 23;14(2):252-257. doi: 10.25259/JNRP_26_2022. PMID: 37181162. Interventional study. ˍ

Huang WH, Huang TY, Lin CM, Mu PF, Lee YY, Liu SH, Hsu SM, Chen YW.
Salvage boron neutron capture therapy for pediatric patients with recurrent diffuse midline glioma.
Childs Nerv Syst. 2023 Feb 23
. doi: 10.1007/s00381-023-05850-2. PMID: 36821007. Observational study˰ ˍ

Matsuda M, Mizumoto M, Kohzuki H, Sugii N, Sakurai H, Ishikawa E.
High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis.
Radiat Oncol. 2023 Feb 23;18(1):38
. doi: 10.1186/s13014-023-02236-1. PMID: 36823671. Observational study. ˍ

Krishnatry R, Mani S, Manjali JJ, Rane PP, Chatterjee A, Goda JS, Janu A, Sahu A, Gupta T, Jalali R.
Institutional Patterns of Care of Diffuse Intrinsic Pontine Glioma.
Neurol India. 2023 Feb 24;71(1):72-78
. doi: 10.4103/0028-3886.370459(?). PMID: 36861577. Observational study. ˍ

Malhotra KP, Kaif M, Malhotra HS, Husain N.
A Novel Case of Primary Conus Medullaris Epithelioid Glioblastoma with Gliosarcomatous Differentiation.
Neurol India. 2023 Feb 24;71(1):132-134
. doi: 10.4103/0028-3886.370454(?) PMID: 36861587. Case report. ˍ

Sangeeta T, Prerana R, Kumar AA, Amarnath J.
Simultaneous Amino Acid PET/MRI - An Opportunity to Assess True Response in Recurrent High-Grade Glioma after Antiangiogenic Therapy.
Neurol India. 2023 Feb 24;71(1):158-159
. doi: 10.4103/0028-3886.370455(?) PMID: 36861599. Letter to the editor, Case report. ˍ


Shahab SW, Schniederjan M, Vega JV, Little S, Reisner A, MacDonald T, Aguilera D.
Case report: ATIC-ALK fusion in infant-type hemispheric glioma and response to lorlatinib.
Front Oncol. 2023 Feb 24;13:1123378. doi: 10.3389/fonc.2023.1123378. PMID: 36910660. Case report. ˍ

Park YW, Han K, Kim S, Kwon H, Ahn SS, Moon JH, Kim EH, Kim J, Kang SG, Chang JH, Kim SH, Lee SK.
Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities.
J Neurooncol. 2023 Feb 25
. doi: 10.1007/s11060-022-04233-y. PMID: 36841906. Observational study. ˍ

Romo CG, Piotrowski AF, Campian JL, Diarte J, Rodriguez FJ, Bale TA, Dahiya S, Gutmann DH, Lucas CG, Prichett L, Mellinghoff I, Blakeley JO.
Clinical, Histological and Molecular Features of Gliomas in Adults with Neurofibromatosis Type 1.
Neuro Oncol. 2023 Feb 25:noad033. doi: 10.1093/neuonc/noad033
. PMID: 36840626. Observational study˰ ˍ

Zhu P, Du XL, Hwang LY, Lairson D, Li R, Esquenazi Y, Zhu JJ.
Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases.
Sci Rep. 2023 Feb 25;13(1):3266
. doi: 10.1038/s41598-023-30017-z. PMID: 36841851. Observational study. ˍ

Waqar U, Ali IFM, Farooqui I, Ahmad S, Chaudhry AA, Angez M, Ziauddin A, Shamim MS.
The effect of preoperative steroids for at least 10 days on complications following craniotomy for tumor resection: A database, retrospective cohort study.
Brain Spine. 2023 Feb 26;3:101725. doi: 10.1016/j.bas.2023.101725. PMID: 37383460. Observational study. ˍ

Aftahy AK, Butenschoen VM, Hoenikl L, Liesche-Starnecker F, Wiestler B, Schmidt-Graf F, Meyer B, Gempt J.
A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis.
BMC Neurol. 2023 Feb 28;23(1):87
. doi: 10.1186/s12883-023-03135-4. PMID: 36855102. Case report. ˍ

Tringale KR, Wolden SL, Karajannis M, Haque S, Pasquini L, Yildirim O, Rosenblum M, Benhamida JK, Cheung NK, Souweidane M, Basu EM, Pandit-Taskar N, Zanzonico PB, Humm JL, Kramer K.
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
J Neurooncol. 2023 Feb 28. doi: 10.1007/s11060-022-04235-w. PMID: 36853490. Interventional study. ˍ